MedPath

Perioperative oral analgesia versus intravenous analgesia for knee arthroscopy, a randomized, double-blinded, non-inferiority trial. OVIKA-trial - S68618

Phase 4
Recruiting
Conditions
Postoperative pain relief after knee arthroscopy
Registration Number
2024-510789-17-00
Lead Sponsor
UZ Leuven
Brief Summary

Evaluating the analgesic effect of oral versus intravenous analgesics postoperative

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing, recruiting
Sex
Not specified
Target Recruitment
108
Inclusion Criteria

Minor knee surgery under general anaesthesia, including arthroscopic meniscectomy and synovectomy, diagnostic arthroscopy, meniscus repair and arthroscopic lavage.

=18 years of age

ASA 1-3 suitable for ambulatory surgery

= 50 kg

Voluntary written informed consent of the participant

Dutch speaking

Exclusion Criteria

History of liver diseases, renal insufficiency, epilepsy, allergy to paracetamol or ibuprofen

Any disorder which, in the Investigator's opinion, might jeopardize the participant's safety or compliance with the protocol

Any prior or concomitant treatment(s) that might jeopardize the participant's safety or that would compromise the integrity of the Trial.

Participation in an interventional Trial with an investigational medicinal product (IMP) or device.

A contraindication for the use of paracetamol or ibuprofen

Non-compliance of the patient

postive urine pregnancy test in women of childbearing potential

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint will be the mean postoperative pain scores measured with the Numeric Rating Scale (NRS) during for minor knee arthroscopy, measured once preoperatively and at different time points postoperatively up to discharge

The primary endpoint will be the mean postoperative pain scores measured with the Numeric Rating Scale (NRS) during for minor knee arthroscopy, measured once preoperatively and at different time points postoperatively up to discharge

Secondary Outcome Measures
NameTimeMethod
Key-secondary: - The need (number of patients) for postoperative rescue medication (morphine or clonidine) and time to readiness for discharge

Key-secondary: - The need (number of patients) for postoperative rescue medication (morphine or clonidine) and time to readiness for discharge

Timepoint-specific NRS for pain during the hospital stay

Timepoint-specific NRS for pain during the hospital stay

NRS for pain 4h after discharge

NRS for pain 4h after discharge

NRS for pain 24h after discharge

NRS for pain 24h after discharge

Mean dose of opioid rescue medication (mean calculated per patient)

Mean dose of opioid rescue medication (mean calculated per patient)

Presence of Post-Operative Nausea and Vomiting (PONV) (at least once)

Presence of Post-Operative Nausea and Vomiting (PONV) (at least once)

Number of times emetics were used after discharge until 24 hours postop

Number of times emetics were used after discharge until 24 hours postop

Analgesic use during the first 24 hours

Analgesic use during the first 24 hours

Economic evaluation

Economic evaluation

Quality of Recovery-40 questionnaire

Quality of Recovery-40 questionnaire

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

UZ Leuven
🇧🇪Leuven, Belgium
An Teunkens
Site contact
+3216344270
an.teunkens@uzleuven.be

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.